AXAxinet
Menu
Finance

Live market screen

Commercial Space Company Risk / Opportunity Ranking

Opportunity/risk view across launch, satellites, SAR, earth observation, defense demand, financing events, and execution risk.

Updated June 27, 2026

Companies analyzed
438
Ranked rows
876
Evidence links
356
Rows per page
20

Opportunity view

Showing rows 221-240 of 438; 20 rows per page.

Sorted by raw opportunity score
RankCompanyScoreThesis / Evidence
221
Payload Aerospace, S.A.
lowweak
Opp 2
Risk 3

Thesis: Only weak opportunity support is visible in these reviewed sources: membership rationale says the company completed a €180M Series C fundraising, but no representative article, no direct positive evidence, and no in-recent evidence window article detail are provided here, so there is not enough cited support to form a strong 1 year+ opportunity thesis.

Why now: Why now is weak because the reviewed sources' coverage debug shows zero article IDs after the March 29, 2026 cutoff and zero evidence after recent evidence window; any older fundraising context may no longer capture current business state. See support references listing article in the membership rationale, but no or article detail is provided in the reviewed sources, so recency and context cannot be independently assessed.

Caveats: No -bearing article detail is provided for the fundraising support article, so factual claims beyond the membership rationale cannot be expanded. Coverage debug shows articles after recent evidence window = 0 and evidence after recent evidence window = 0, limiting confidence.

222
Pilot Photonics
lowweak
Opp 2
Risk 1

Thesis: Membership rationale says Pilot Photonics secured a €1 million ESA contract for space photonics development and that the technology addresses satellite communication demands, which could support a modest long-horizon opportunity thesis if contract execution expands.

Why now: Why now is limited because only membership rationale references article: and the reviewed sources provide no or retained evidence after recent evidence window.

Caveats: The ESA contract claim cannot be elevated strongly without the underlying article or summary in the reviewed sources. Coverage data shows evidence after recent evidence window 0. Opportunity may be real, but reviewed sources support is too sparse for higher conviction.

223
Pixxel
lowweak
Opp 2
Risk 1

Thesis: Pixxel has a plausible long-horizon opportunity narrative from an external article summary describing a Pixxel-led consortium winning an Indian EO constellation PPP, but that article is dated October 13, 2025 and was dropped by the 90-day recent evidence window, so it cannot support a current ranking thesis.

Why now: Why now is weak because the only cited article summary in the reviewed sources are outside the 90-day evidence window, October 13, 2025

Caveats: The representative article for Pixxel is outside the recent evidence window and evidence recent evidence review shows kept_rows 0. No retained structured positive or negative rows are available.

224
Reliance Industries Limited
lowweak
Opp 2
Risk 2

Thesis: There is a possible long-horizon opportunity if Reliance, via Jio Platforms, advances its described LEO satellite communications ambitions, but the reviewed sources does not retain representative article details, or within the recent evidence window evidence to ground that as a current high-conviction thesis.

Why now: Why now is weak because although the phase-2 rationale references articles, and: regarding LEO satellite communication plans, no or retained evidence are available and coverage data shows articles after recent evidence window of 0.

Caveats: Phase-2 rationale suggests planning activity, not confirmed operating status, and cannot be cited as fact without /evidence. No representative articles or evidence are available after recent evidence window. Scores are constrained by insufficient retained evidence, not by a definitive neutral business view.

225
Remondo
lowweak
Opp 2
Risk 2

Thesis: Older context suggests a potentially differentiated Earth-observation approach, with a first mission planned in 2027 to demonstrate a partial aperture imaging system, but this falls outside the active evidence recent evidence window and is insufficient for a strong current rank.

Why now: The only concrete article summary is dated February 23, 2026 and therefore outside the 90-day recent evidence window cutoff of March 29, 2026; it says Remondo plans to launch its first mission in 2027 to demonstrate PAIS, which is interesting for long-horizon monitoring but not strong enough for a current thesis.

Evidence
  • February 23, 2026: Remondo plans to launch its first mission in 2027 to demonstrate what it calls a partial aperture imaging system, or PAIS. spacenews.com
  • The article frames the key milestone as a planned first mission in 2027, implying development-stage execution risk; however, this evidence is outside the recent evidence window. spacenews.com

Caveats: All dated evidence was dropped by the 90-day recent evidence filter. Only one older article is available, so corroboration is limited.

226
Rhea Space Activity
lowweak
Opp 2
Risk 2

Thesis: The membership rationale says Rhea Space Activity raised about $6 million in Series A financing for GPS-denied navigation software targeting military and intelligence customers, which would be a constructive long-horizon signal if confirmed by available evidence, but this screen contains no usable within the recent evidence window evidence or article.

Why now: Why now is limited because no within the recent evidence window evidence were retained for ranking, so recency and durability cannot be tested.

Caveats: Phase-2 membership rationale references, but no or available evidence row is provided in these reviewed sources. Coverage debug shows articles after recent evidence window = 0 and evidence after recent evidence window = 0. The financing claim cannot be elevated beyond low conviction without direct available evidence.

227
Rocket One, Inc.
lowweak
Opp 2
Risk 2

Thesis: Among this screen, Rocket One has the strongest contextual indication of a strategic pivot toward space/defense AI chips and nano-launch or nanosatellite enablement, which could become a long-horizon opportunity if later corroborated by direct execution evidence. However, these reviewed sources have no direct positive evidence inside the recent evidence window, so the thesis remains weak.

Why now: Membership rationale cites articles, and: describing a renamed former biotech company pivoting toward space/defense AI chips and nano-launch or nanosatellite enablement, but coverage data still shows articles after recent evidence window = 0 and evidence after recent evidence window = 0. unavailable in reviewed sources.

Caveats: Context suggests strategic intent, not proven execution. No article are provided for cited membership-rationale articles. No direct evidence survive recent evidence filtering.

228
Rogue Space Systems
lowweak
Opp 2
Risk 1

Thesis: There is limited relevance support that Rogue Space Systems is an operating in-orbit servicing company, which is directionally compatible with a long-horizon commercial space opportunity view, but the evidence is only undated directory-style context and not direct positive operating proof.

Why now: The only retained evidence is an undated external sector page listing Rogue Space Systems as an operating in-orbit servicing company, so the why-now is weak and recency is uncertain.

Evidence
  • Space Index lists Rogue Space Systems, HQ Laconia, New Hampshire, USA, status 'operating' within 'In-Orbit Servicing & Assembly Companies.' This is undated supporting article context. spaceindex.io

Caveats: Evidence is undated and explicitly not recency proof per reviewed sources policy. Same-article repeated rows are not independent confirmation. No direct evidence of contracts, funding, milestones, or setbacks is included.

229
RTX Corporation
lowweak
Opp 2
Risk 2

Thesis: The reviewed sources' membership rationale references involvement in U.S. Space Force and missile-warning programs, which could support long-horizon opportunity, but no within the recent evidence window direct evidence or representative article summaries are available for scoring in this screen.

Why now: Although the membership rationale references articles, and: the reviewed sources loads zero reviewed evidence after recent evidence filtering, so there is no directly scorable current catalyst from local evidence.

Caveats: Very large article universe exists, but article count is not conviction. Membership support references potentially meaningful articles, but those summaries/evidence are not available here and therefore cannot be elevated into direct scoring evidence.

230
Sanyark Space Technologies
lowweak
Opp 2
Risk 1

Thesis: The reviewed sources places Sanyark Space Technologies in a spacetech accelerator among startups working on rocket propulsion, satellites, and space energy. That supports a possible early-stage opportunity setup, but the reviewed sources does not specify which activities belong to Sanyark itself and provides no direct evidence row or (: not provided in reviewed sources).

Why now: There is no supported timing edge because the reviewed sources have zero direct evidence after recent evidence window and no dated article details beyond the structure.

Caveats: Accelerator participation is weaker than company-specific funding or contract evidence. The article appears to describe a cohort rather than a company-specific event. No, quote, or direct event row is available.

231
Satellogic Inc.
lowweak
Opp 2
Risk 2

Thesis: The reviewed sources membership rationale describes Satellogic as an Earth observation/geospatial company with constellation and monitoring contracts, which could be constructive over a 1 year+ horizon, but no available current evidence supports a stronger call.

Why now: Why-now support is absent because coverage data shows zero evidence after recent evidence window.

Caveats: Phase2 rationale cites 2026-04, and: but no representative articles or evidence are available for direct citation. Coverage data reports articles after recent evidence window = 0 and evidence after recent evidence window = 0. Low score reflects missing current reviewed sources evidence rather than negative evidence.

232
SatixFy
lowweak
Opp 2
Risk 2

Thesis: Phase-2 rationale references SatixFy as an Israeli chipmaker acquired by MDA Space with first space-grade chips shipped, which may indicate strategic relevance, but there are no retained in-window evidence here.

Why now: The reviewed sources includes no representative article or evidence row inside the 90-day recent evidence window, so there is no dated near-current catalyst to anchor a 1 year+ view from this screen alone.

Caveats: No retained evidence after recent evidence window. Referenced acquisition/shipment facts are only in the phase-2 rationale here, not in cited retained evidence.

233
SatSure Analytics India Pvt. Ltd.
lowweak
Opp 2
Risk 2

Thesis: Reviewed evidence context indicates SatSure is developing a large Earth Observation AI model and received IN-SPACe Technology Adoption Fund support including a ₹24.6 crore grant, which could support longer-horizon capability building, but no direct post-recent evidence window evidence are available to validate timing, scale, or current business momentum in the next 1 year+ horizon.

Why now: There is no reliable 'why now' catalyst in the available evidence. The reviewed sources notes support/article IDs were used for membership, but after the 90-day recent evidence filter there were 0 article IDs after recent evidence window and 0 evidence available, so recency is uncertain for any thesis.

Caveats: No direct evidence available after recent evidence window for this company. Membership rationale references article IDs, and: but the reviewed sources does not provide or article summaries for citation. Without -bearing evidence, factual support is limited to reviewed sources-level membership rationale only.

234
SatVu
lowweak
Opp 2
Risk 1

Thesis: An external article says SatVu closed a £30m funding round, which is positive financing context, but that article is dated February 17, 2026 and was dropped by the 90-day recent evidence policy, so it cannot support a strong current opportunity ranking

Why now: There is no usable within the recent evidence window evidence after filtering; the only cited article is older than the March 29, 2026 cutoff and therefore not timely support for a 1 year+ ranking under these reviewed sources' evidence policy.

Caveats: The reviewed sources report zero kept rows after recent evidence window for SatVu. Older funding evidence exists but was dropped by policy, so recency is insufficient for a stronger score.

235
Scale AI
lowweak
Opp 2
Risk 1

Thesis: Membership rationale says Scale AI received a U.S. Space Force Golden Dome contract as part of an approximately $3.2 billion award group, which, if current and durable, could support a meaningful public-sector space/defense opportunity over a 1 year+ horizon.

Why now: Why now is muted because the reviewed sources references support article in membership rationale, but no, article summary, or retained evidence after the 90-day filter are available to confirm timing or scope.

Caveats: Despite 273 articles considered, coverage data shows articles after recent evidence window 0 and evidence after recent evidence window 0. The contract claim is only present in membership rationale citing article without a in the served reviewed sources. Opportunity score is kept low because the the evidence standard require direct positive evidence, not just membership inclusion.

236
Schaeffler AG
lowweak
Opp 2
Risk 1

Thesis: The reviewed sources rationale says Schaeffler planned a collaboration with Spire on satellite bus manufacturing and RF sensing, which suggests strategic adjacency to space systems, but there is no available within the recent evidence window direct evidence to underwrite a durable opportunity thesis.

Why now: No surviving 90-day evidence are available despite 94 articles considered. The only support is the membership rationale reference to: but the reviewed sources provide no and no retained evidence.

Caveats: Membership rationale is not sufficient directional proof. No direct positive or negative evidence survived the recent evidence window. Industrial-partner status versus core space-company status is unclear from the reviewed sources.

237
SEALCOIN AG
lowweak
Opp 2
Risk 1

Thesis: There is a hint of financing-related progress in space-based blockchain infrastructure, but the reviewed sources lack retained direct evidence strong enough to support a robust opportunity thesis.

Why now: The membership rationale says SEALCOIN secured strategic investment for space-based blockchain infrastructure leveraging a satellite constellation, tied to article: but no or retained evidence are present after recent evidence window.

Caveats: Only rationale-level description is available; no retained direct evidence row with is supplied. The business category fit is ambiguous in the reviewed sources itself.

238
Sidus Space Inc.
lowweak
Opp 2
Risk 3

Thesis: The membership rationale indicates Sidus Space operates LizzieSat satellites, manufacturing, and customer contracts, which could support a long-horizon operating-space-company thesis, but this screen includes no available within the recent evidence window article summaries or evidence to evaluate direction.

Why now: Why now is weak because although the company had 44 considered articles, the reviewed sources show articles after recent evidence window = 0 and evidence after recent evidence window = 0, so the current business state is not evidenced here.

Caveats: Phase-2 membership rationale references: and: but no or available evidence are provided. A large historical article universe should not be mistaken for conviction. No within the recent evidence window direct evidence is available for ranking.

239
Sift
lowweak
Opp 2
Risk 2

Thesis: The reviewed sources hints at potential opportunity from Sift raising $42 million and building AI infrastructure for mission-critical hardware including space and defense, but no kept citable evidence or are provided here.

Why now: Why now is weak because only article is referenced in the membership rationale, with no and no reviewed evidence to validate timing or materiality for the ranking horizon.

Caveats: No article is available for article. Space exposure may be indirect rather than core. Coverage debug shows zero post-recent evidence window evidence.

240
Silicon Microgravity
lowweak
Opp 2
Risk 2

Thesis: There is modest theoretical opportunity because the reviewed sources' membership rationale says Silicon Microgravity received £500K in UK space funding, but no reviewed evidence row or citable article is supplied here.

Why now: Why now is weak because the only support referenced is article: in the membership rationale, and the reviewed sources provide neither a nor a reviewed evidence row to substantiate timing beyond that summary.

Caveats: No article is available for article Coverage debug shows zero post-recent evidence window evidence for ranking. Funding support alone, even if true, would not establish durable attractiveness without additional execution evidence.

Risk view

Showing rows 201-220 of 438; 20 rows per page.

Sorted by raw risk score
RankCompanyScoreThesis / Evidence
201
QOSMIC
lowweak
Opp 4
Risk 2

Thesis: Main risk is execution and evidence uncertainty rather than a documented adverse event. The reviewed sources only provides undated supporting article context about a seed round and intended use of proceeds, which leaves recency, funding durability, and commercialization progress uncertain.

Why now: Why now is weak because the only support is undated context articles; the reviewed sources explicitly says no is available, so recency-sensitive claims should be treated cautiously for these funding and expansion statements

Evidence
  • Article summary says QOSMIC secured $3.33 million in seed funding led by Accel and Prosus, with investment to support engineering expansion, manufacturing scale-up and deployment of optical communication terminals. bwdisrupt.com
  • Article summary says Qosmic raised $3.3 million in seed funding to build optical communications infrastructure for space. startup.economictimes.indiatimes.com

Caveats: Evidence is undated; recency is uncertain. Support is supporting article context only, not direct structured positive event evidence. Same funding story appears in two articles and should not be treated as independent confirmation.

202
Quantum Space
lowweak
Opp 4
Risk 2

Thesis: The reviewed sources provide no retained article or evidence after recent evidence window to quantify contract size, award stage, revenue timing, or execution burden, so the opportunity is plausible but not well-validated and downside cannot be measured.

Why now: The reviewed sources provide no post-recent evidence window detailed evidence, but the membership rationale specifically references selection for the Andromeda program via article. Because the underlying article summary/ is not included here, timing and magnitude are uncertain.

Caveats: No representative article or is included for the cited Andromeda selection evidence. Selection for a program is positive, but without award size or timing the business impact is unclear. Scores are capped by missing direct article-level support.

203
Relativity Space
lowweak
Opp 1
Risk 2

Thesis: Risk is slightly higher than base because the company is described only through older membership rationale involving development of the Terran R reusable rocket and financing participation, without current evidence confirming execution progress, but this remains low-conviction because no direct negative evidence is retained.

Why now: Why now is weak because there are no retained post-cutoff article summaries or evidence in the reviewed sources.

Caveats: No retained evidence after recent evidence window. The modest risk uplift reflects uncertainty from lack of current confirmation, not a direct adverse event.

204
Reliance Industries Limited
lowweak
Opp 2
Risk 2

Thesis: There is also strategy-execution risk because the phase-2 rationale says the project is early stage with no final timeline or finalized investment, but again the reviewed sources does not provide retained article-level citations for those statements here, so risk remains low-scored due to weak grounding.

Why now: Why now is weak because although the phase-2 rationale references articles, and: regarding LEO satellite communication plans, no or retained evidence are available and coverage data shows articles after recent evidence window of 0.

Caveats: Phase-2 rationale suggests planning activity, not confirmed operating status, and cannot be cited as fact without /evidence. No representative articles or evidence are available after recent evidence window. Scores are constrained by insufficient retained evidence, not by a definitive neutral business view.

205
Remondo
lowweak
Opp 2
Risk 2

Thesis: The reviewed sources supports some development-stage and timing risk because the cited milestone is still a planned future demonstration mission in 2027, but the evidence is old and sparse.

Why now: The only concrete article summary is dated February 23, 2026 and therefore outside the 90-day recent evidence window cutoff of March 29, 2026; it says Remondo plans to launch its first mission in 2027 to demonstrate PAIS, which is interesting for long-horizon monitoring but not strong enough for a current thesis.

Evidence
  • The article frames the key milestone as a planned first mission in 2027, implying development-stage execution risk; however, this evidence is outside the recent evidence window. spacenews.com
  • February 23, 2026: Remondo plans to launch its first mission in 2027 to demonstrate what it calls a partial aperture imaging system, or PAIS. spacenews.com

Caveats: All dated evidence was dropped by the 90-day recent evidence filter. Only one older article is available, so corroboration is limited.

206
Rhea Space Activity
lowweak
Opp 2
Risk 2

Thesis: Risk is mostly uncertainty from missing current evidence rather than explicit adverse developments. Without available direct evidence, it is hard to assess whether financing, product progress, or customer conversion remains on track.

Why now: Why now is limited because no within the recent evidence window evidence were retained for ranking, so recency and durability cannot be tested.

Caveats: Phase-2 membership rationale references, but no or available evidence row is provided in these reviewed sources. Coverage debug shows articles after recent evidence window = 0 and evidence after recent evidence window = 0. The financing claim cannot be elevated beyond low conviction without direct available evidence.

207
Rocket Factory Augsburg
lowweak
Opp 1
Risk 2

Thesis: As an apparent pre-launch rocket company, execution risk may be elevated, but the reviewed sources does not provide retained adverse evidence, so only a modest evidence-light risk score is justified.

Why now: No retained article or event evidence remains after recent evidence filtering; the only hint is a membership rationale referencing first test-launch focus via article: without an included summary.

Caveats: Cannot treat membership rationale alone as strong directional proof. No article summary or retained evidence row is included for article

208
Rocket One, Inc.
lowweak
Opp 2
Risk 2

Thesis: The same contextual pivot language also creates execution and qualification risk because the reviewed sources does not firmly establish Rocket One as a current operating space company in the target categories, and there is no direct post-recent evidence window evidence of contracts, product milestones, financing, or customer traction.

Why now: Membership rationale cites articles, and: describing a renamed former biotech company pivoting toward space/defense AI chips and nano-launch or nanosatellite enablement, but coverage data still shows articles after recent evidence window = 0 and evidence after recent evidence window = 0. unavailable in reviewed sources.

Caveats: Context suggests strategic intent, not proven execution. No article are provided for cited membership-rationale articles. No direct evidence survive recent evidence filtering.

209
RTX Corporation
lowweak
Opp 2
Risk 2

Thesis: No material adverse evidence is available in the reviewed sources for RTX, so there is no supported risk thesis from the provided evidence.

Why now: Although the membership rationale references articles, and: the reviewed sources loads zero reviewed evidence after recent evidence filtering, so there is no directly scorable current catalyst from local evidence.

Caveats: Very large article universe exists, but article count is not conviction. Membership support references potentially meaningful articles, but those summaries/evidence are not available here and therefore cannot be elevated into direct scoring evidence.

210
Satellogic Inc.
lowweak
Opp 2
Risk 2

Thesis: No material adverse evidence is available, but there is also no current direct evidence to establish momentum or deterioration.

Why now: Why-now support is absent because coverage data shows zero evidence after recent evidence window.

Caveats: Phase2 rationale cites 2026-04, and: but no representative articles or evidence are available for direct citation. Coverage data reports articles after recent evidence window = 0 and evidence after recent evidence window = 0. Low score reflects missing current reviewed sources evidence rather than negative evidence.

211
SatixFy
lowweak
Opp 2
Risk 2

Thesis: No direct adverse evidence is available, but lack of current evidence means the reviewed sources cannot support a strong opportunity or risk thesis.

Why now: The reviewed sources includes no representative article or evidence row inside the 90-day recent evidence window, so there is no dated near-current catalyst to anchor a 1 year+ view from this screen alone.

Caveats: No retained evidence after recent evidence window. Referenced acquisition/shipment facts are only in the phase-2 rationale here, not in cited retained evidence.

212
SatSure Analytics India Pvt. Ltd.
lowweak
Opp 2
Risk 2

Thesis: The main risk is evidentiary: no direct adverse evidence is available, but there is also no in-window evidence confirming current execution, funding status, customer traction, or program progress, limiting confidence in any opportunity case.

Why now: There is no reliable 'why now' catalyst in the available evidence. The reviewed sources notes support/article IDs were used for membership, but after the 90-day recent evidence filter there were 0 article IDs after recent evidence window and 0 evidence available, so recency is uncertain for any thesis.

Caveats: No direct evidence available after recent evidence window for this company. Membership rationale references article IDs, and: but the reviewed sources does not provide or article summaries for citation. Without -bearing evidence, factual support is limited to reviewed sources-level membership rationale only.

213
SEALSQ Corp
lowweak
Opp 1
Risk 2

Thesis: Main risk is evidence opacity rather than explicit adverse business events: the reviewed sources show 47 articles considered but zero article IDs after recent evidence window and zero evidence available after dedupe, leaving business-state recency uncertain.

Why now: Why now is weak because the 90-day reviewed sources contain no available evidence after recent evidence window for SEALSQ, despite article history existing in the broader corpus.

Caveats: No direct positive or negative evidence available after recent evidence window. Membership rationale references article IDs and, but the reviewed sources provide no for them, so they cannot be cited as factual support under the the evidence standard.

214
SES
mediummedium
Opp 6
Risk 2

Thesis: The reviewed sources show no direct adverse evidence. Main risk is that the available evidence is supporting article context rather than a fuller company-specific contract filing, and one related transportation agreement is older than the recent evidence window.

Why now: The key evidence is recent and within the recent evidence window: a June 11, 2026 SpaceNews article says SES was selected last month as a prime contractor under the PTS-G program, with K2 Space providing SES's satellite platform

Evidence
  • SpaceNews says communications satellite operators SES and Viasat were selected as prime contractors under a combined $437.7 million award to each build and operate a satellite for the U.S. Space Force Protected Tactical Satcom-Global program; article dated June 11, 2026. spacenews.com

Caveats: Reviewed evidence is still supporting article context rather than a direct company filing. The Impulse transportation agreement is older and outside the 90-day recent evidence window.

215
Sierra Nevada Corporation
mediummedium
Opp 4
Risk 2

Thesis: The main risk is evidentiary rather than operational: the reviewed sources itself says mapping between Sierra Nevada Corporation and Sierra Space is not fully explicit, and the surviving support is supporting article context rather than direct company events.

Why now: The key surviving context is dated April 8, 2026, within the 90-day recent evidence window, and references recent contract awards under Andromeda that could matter over a 1 year+ horizon if they convert into meaningful program work. Article timestamp: April 8, 2026, basis: source date. Evidence is from at

Evidence
  • U.S. Space Force's Space Systems Command awarded 14 companies more than $1.8 billion in firm fixed price 'Andromeda' contracts; the listed companies include Sierra Space. April 8, 2026. defensedaily.com

Caveats: Evidence is supporting article context, not a direct structured positive event row for Sierra Nevada Corporation. Reviewed evidence explicitly notes entity-resolution ambiguity between Sierra Nevada Corporation and Sierra Space. The second representative article is older than the 90-day recent evidence window and should not drive recency, published September 2, 2025.

216
Sift
lowweak
Opp 2
Risk 2

Thesis: Risk is mainly thesis slippage risk: the company may be an enabling software layer rather than a direct space operator, and the reviewed sources contain no direct business traction or adverse evidence for ranking.

Why now: Why now is weak because only article is referenced in the membership rationale, with no and no reviewed evidence to validate timing or materiality for the ranking horizon.

Caveats: No article is available for article. Space exposure may be indirect rather than core. Coverage debug shows zero post-recent evidence window evidence.

217
Silicon Microgravity
lowweak
Opp 2
Risk 2

Thesis: Risk is mainly execution and information opacity risk because the reviewed sources lack direct dated rows on revenue, contracts, milestones, or setbacks.

Why now: Why now is weak because the only support referenced is article: in the membership rationale, and the reviewed sources provide neither a nor a reviewed evidence row to substantiate timing beyond that summary.

Caveats: No article is available for article Coverage debug shows zero post-recent evidence window evidence for ranking. Funding support alone, even if true, would not establish durable attractiveness without additional execution evidence.

218
SKY Perfect JSAT
lowweak
Opp 3
Risk 2

Thesis: The same evidence is weak for timing because it is undated supporting article context rather than direct event/fact evidence, so current economic significance and sequencing are uncertain

Why now: This is one of the only companies in the screen with any current evidence surviving the recent evidence window, but it is undated supporting context, so why-now confidence is still limited

Evidence
  • Strategic partnership with Astroscale for on-orbit servicing; includes an investment by SKY Perfect JSAT. The reviewed sources marks this as undated supporting article context, not recency proof. spaceanddefense.io

Caveats: Evidence is undated and supporting article context only. Same article appears in multiple weak-context rows and is not independent confirmation. No direct positive event/fact beyond supporting context.

219
Space Forge
lowweak
Opp 2
Risk 2

Thesis: Risk is primarily uncertainty and execution risk because no direct positive or negative rows are preserved in the ranking reviewed sources despite the membership rationale referencing funding and technology progress.

Why now: Why now is weak because the reviewed sources cites articles: and: in the membership rationale, but no or reviewed evidence are provided for ranking-grade citation.

Caveats: No article are provided for the referenced support articles. Cannot convert broad space-tech relevance into a strong opportunity thesis without direct evidence. Coverage after recent evidence window is empty.

220
SpaceLogistics (Northrop Grumman)
lowweak
Opp 1
Risk 2

Thesis: Primary risk in this ranking is stale evidence: there is no retained within the recent evidence window evidence to confirm current contracts, fleet expansion, or demand. That makes the near-current business state uncertain in these reviewed sources.

Why now: Why now is weak because the only cited article, March 4, 2025), falls outside the 90-day recent evidence window and was dropped; recency therefore does not support an active thesis here.

Caveats: No evidence were kept after recent evidence filtering. Cannot rely on dropped 2025 evidence for a current ranking. Company-category relevance is not sufficient for a directional opportunity thesis.